Bridging the gap between science fiction and reality, a Chinese robotics firm on Tuesday unveiled a manned “mecha” capable of transitioning between bipedal walking and four-legged mode. Developed by Unitree Robotics, the GD01 – resembling an Autobot from a Transformers movie – is a high-strength alloy machine designed for civilian transport. It weighs 500kg with a pilot on board – roughly the weig...
Bridging the gap between science fiction and reality, a Chinese robotics firm on Tuesday unveiled a manned “mecha” capable of transitioning between bipedal walking and four-legged mode. Developed by Unitree Robotics, the GD01 – resembling an Autobot from a Transformers movie – is a high-strength alloy machine designed for civilian transport. It weighs 500kg with a pilot on board – roughly the weight of a grand piano – and carries a starting price of 3.9 million yuan (US$573,674), according to...
FG Trade/E+ via Getty Images Here at the Lab, we were not very lucky with our Viatris Inc. ( VTRS ) coverage initiation , which happened just a few days before the Middle East escalation. That said, we reported a positive total return since then (Fig. 1), and the company released supportive Q1 2026 results and, more importantly, presented new medium-term targets in a New York investor day. Our buy...
FG Trade/E+ via Getty Images Here at the Lab, we were not very lucky with our Viatris Inc. ( VTRS ) coverage initiation , which happened just a few days before the Middle East escalation. That said, we reported a positive total return since then (Fig. 1), and the company released supportive Q1 2026 results and, more importantly, presented new medium-term targets in a New York investor day. Our buy rating was supported by 1) positive pipeline catalysts expected in 2026–2027 with growth reacceleration and margin expansion, 2) a FCF yield above 10% with deleveraging capacity, and 3) a valuation re-rating thanks to earnings visibility improvement. Mare Ev. Lab Rating Update Fig. 1. Q1 Results The company started 2026 with Q1 top-line sales of $3.5 billion (Fig. 2), an 8% year-over-year increase. Performance was mainly supported by continued momentum in Greater China, alongside resilient demand across branded products and emerging markets. Viatris delivered an adjusted EBITDA increase of 10%, driven by commercial execution and a better GEO mix, particularly in Greater China (Fig. 3). The company also beat Wall Street expectations, reporting diluted EPS of $0.59. For the above reason, the company reiterated its full-year 2026 guidance. More importantly, the company continues to focus on higher-growth therapeutic areas and emphasizes ongoing progress in strengthening its product pipeline. Viatris Q1 Financials in a Snap Fig. 2. Viatris China Positive Results Fig. 3. Why are we positive? We came away from Viatris’ Q1 results with increased confidence in the company's outlook. Management's commitment to Viatris’s growth strengthens our high-conviction equity investment. While the growth narrative had already been gradually improving, the introduction of a defined long-term framework provides a more credible anchor for investors (and Wall Street analysts). Top-line sales were notably ahead of expectations. In numbers, Viatris' midpoint of a five-year CAGR target (3.5%—Fig. 4)...
Canada expects to conclude free trade agreements with the Philippines and the wider Southeast Asian bloc this year, as Ottawa seeks to boost business ties with the region and grow its non-US trade. “Negotiations are really going well,” visiting Canadian International Trade Minister Maninder Sidhu said in an interview on Tuesday, after meeting with Philippine Trade Secretary Cristina Roque and Fina...
Canada expects to conclude free trade agreements with the Philippines and the wider Southeast Asian bloc this year, as Ottawa seeks to boost business ties with the region and grow its non-US trade. “Negotiations are really going well,” visiting Canadian International Trade Minister Maninder Sidhu said in an interview on Tuesday, after meeting with Philippine Trade Secretary Cristina Roque and Finance Secretary Frederick Go . Sidhu said Canada is also joining the Luzon Economic Corridor, a project backed by the US and Japan and where Ottawa is putting in C$2 million ($1.5 million). “It sends a signal to the Canadian businesses out there that want to look at investing in the Luzon Economic Corridor that Canada’s skin is in the game.” Potential investments include data center, logistics and energy, he said. Read More: US Plans 4,000-Acre Hub in Philippines to Boost Supply Chains In pursuing free trade with the Philippines, Canada is looking at Manila’s expanding middle class, which bodes well with its agriculture exports, according to the minister. Canada and the Association of Southeast Asian Nations agreed to start free trade talks in late 2021, when “the world was in a different place,” Sidhu said. Prime Minister Mark Carney is committed to diversifying the nation’s trading partners and there’s a political will to conclude the Canada-Asean FTA, he added. Carney last year laid out a strategy to double Canada’s exports to markets outside the US within a decade to net an extra C$300 billion in trade. Sidhu, who is also scheduled to meet with Manila’s Defense Secretary Gilberto Teodoro Jr. , said Canada similarly wants to be a defense supplier to the Philippines which is aiming to modernize its military capabilities. Canada and the Philippines signed a visiting forces agreement last year, and it deployed troops during the annual flagship US-Philippines military drills that ended last week. Read More: Philippines Inks Military Pact With Canada in Bid to Deter China
Earnings Call Insights: Hims & Hers Health (HIMS) Q1 2026 Management View "It's been a strong, meaningful start to the year at Hims & Hers... 2026 has proven to be a year of accelerating growth, which reinforces our confidence in our ambitious 2030 targets." (Co-Founder, Chairman & CEO Andrew Dudum) "In March, we announced a strategic shift in our weight loss business... focuses on providing custo...
Earnings Call Insights: Hims & Hers Health (HIMS) Q1 2026 Management View "It's been a strong, meaningful start to the year at Hims & Hers... 2026 has proven to be a year of accelerating growth, which reinforces our confidence in our ambitious 2030 targets." (Co-Founder, Chairman & CEO Andrew Dudum) "In March, we announced a strategic shift in our weight loss business... focuses on providing customers on our platform with access to the broadest possible assortment of innovative medications." (CEO Dudum) "Within 6 weeks of introducing direct access to Novo Nordisk's GLP-1 products to our platform, we have fulfilled more than 125,000 shipments for Wegovy products." (CEO Dudum) "We expect our planned acquisition of Eucalyptus to close in the second half of this year." (CEO Dudum) "We believe our investment in YourBio's microneedle blood sampling technology will make deeper health insights across key biomarkers even easier to access." (CEO Dudum) "We now have nearly 40 members in our AI team..." and "we currently have an AI copilot live on the provider side of the platform." (Chief Technology Officer Mohamed ElShenawy) "In March, we made a deliberate strategic pivot within our weight loss specialty..." (Chief Financial Officer Yemi Okupe) Outlook "In the second quarter, we are anticipating revenue in the range of $680 million to $700 million" and "we expect adjusted EBITDA to be between $35 million to $55 million." (CFO Okupe) "For the full year, we are raising our 2026 revenue outlook to $2.8 billion to $3 billion" and "we expect... adjusted EBITDA will be between $275 million and $350 million." (CFO Okupe) "We expect gross margins to compress as we prioritize scaling areas such as weight loss, labs and international markets" and "near-term margin headwinds are expected in the second quarter as the majority of our weight loss specialty moves toward 1-month shipments." (CFO Okupe) Compared with the prior quarter’s initial 2026 outlook of "$2.7 billion to $2.9 billion" r...
UniCredit SpA is arranging two significant risk transfers tied to over €3 billion ($3.5 billion) of company loans for two Spanish lenders as well as nearing completion of a similar deal at its own German unit. Milan-based UniCredit is organizing SRTs for CaixaBank SA and Banco Sabadell SA , according to people familiar with the matter who asked not to be identified discussing private transactions....
UniCredit SpA is arranging two significant risk transfers tied to over €3 billion ($3.5 billion) of company loans for two Spanish lenders as well as nearing completion of a similar deal at its own German unit. Milan-based UniCredit is organizing SRTs for CaixaBank SA and Banco Sabadell SA , according to people familiar with the matter who asked not to be identified discussing private transactions. Its own German deal is tied to around €3.5 billion of loans to large corporates, the people added. European banks are issuing SRTs at a record pace as investors line up for returns that frequently exceed 10%. Lenders typically use the instruments to insure between 5% and 15% of a loan portfolio, freeing up regulatory capital or managing concentration risks in certain sectors or borrowers. That in turn increases their leeway to pursue growth or bolster payouts to shareholders. UniCredit is one of the most prolific issuers of SRTs out of its own loan book. It has also been helping other banks such as Austria’s Bawag Group AG and Commerbank AG ’s Polish unit on transactions tied to portfolios of credit card receivables and commercial real estate loans , respectively, Bloomberg reported last month. Read more: Banks Use SRTs to Hedge Rising Default Risk in Real Estate CaixaBank’s SRT is tied to around €2 billion of loans to companies, while the Sabadell transaction is linked to around €1.25 billion of loans to small and mid-size enterprises, the people said. Representatives of UniCredit, CaixaBank and Sabadell declined to comment. SRT activity has continued apace despite global market volatility triggered by war in the Middle East. Banco Santander SA , Societe Generale SA and Erste Group Bank AG are among lenders currently discussing potential deals with investors.
Thapana Onphalai AST SpaceMobile ( ASTS ) shares fell 12% in premarket trading on Tuesday after the company reported weaker-than-expected quarterly results while reaffirming its outlook and stating it remains on track to achieve full-year 2026 revenue guidance of $150M to $200M. For the second quarter of 2026, the company estimates adjusted operating expenses, excluding the adjusted cost of revenu...
Thapana Onphalai AST SpaceMobile ( ASTS ) shares fell 12% in premarket trading on Tuesday after the company reported weaker-than-expected quarterly results while reaffirming its outlook and stating it remains on track to achieve full-year 2026 revenue guidance of $150M to $200M. For the second quarter of 2026, the company estimates adjusted operating expenses, excluding the adjusted cost of revenues, will increase to the range of ~$85M to $95M. Additionally, capital expenditures are expected to increase in Q2 to a range of $575M to $650M , primarily driven by the timing of near-term launch payments. Regarding risks and concerns, the company noted that launch reliability and schedule risks were directly addressed following BlueBird 7, adding that teams are currently working through the investigation into an upper-stage anomaly. Meanwhile, commercial activation risk remained tied to integration and milestone timing; “Quarterly revenue will likely vary significantly depending on achievement of milestones and the timing of customer activities,” CFO Andrew Johnson said. "Cost and execution risk around scaling was underscored by higher planned Q2 spending." The company's shares have advanced ~14% YTD. More on AST SpaceMobile AST SpaceMobile, Inc. (ASTS) Q1 2026 Earnings Call Transcript AST SpaceMobile, Inc. 2026 Q1 - Results - Earnings Call Presentation Earnings Preview On AST SpaceMobile: Strong Buy Due To Growth Prospects AST SpaceMobile targets ~45 BlueBird satellites in orbit by end of 2026 while reiterating $150M-$200M revenue guidance AST SpaceMobile GAAP EPS of -$0.66 misses by $0.46, revenue of $14.74M misses by $21.84M
Trican Well Service ( TOLWF ) declares CAD 0.055/share quarterly dividend , in line with previous. Forward yield 3.26% Payable June 30; for shareholders of record June 15; ex-div June 15. See TOLWF Dividend Scorecard, Yield Chart, & Dividend Growth. More on Trican Well Service Ltd. Trican Well Service: Strong Execution Leads To Strong Cash Flows Trican Well Service Ltd. (TCW:CA) Q4 2025 Earnings C...
Trican Well Service ( TOLWF ) declares CAD 0.055/share quarterly dividend , in line with previous. Forward yield 3.26% Payable June 30; for shareholders of record June 15; ex-div June 15. See TOLWF Dividend Scorecard, Yield Chart, & Dividend Growth. More on Trican Well Service Ltd. Trican Well Service: Strong Execution Leads To Strong Cash Flows Trican Well Service Ltd. (TCW:CA) Q4 2025 Earnings Call Transcript Trican Well Service reports Q4 results Historical earnings data for Trican Well Service Ltd. Dividend scorecard for Trican Well Service Ltd.
Stanislav Hubkin/iStock via Getty Images It's safe to say the market loved what it saw from Texas Roadhouse ( TXRH ). The stock simply soared double digits in last Friday's session and was probably the best earnings report I've read so far in Q1. Seeking Alpha Same-store sales keep accelerating, traffic was an eye-popping positive 4.5%, AUVs are still huge, and Texas Roadhouse is clearly taking sh...
Stanislav Hubkin/iStock via Getty Images It's safe to say the market loved what it saw from Texas Roadhouse ( TXRH ). The stock simply soared double digits in last Friday's session and was probably the best earnings report I've read so far in Q1. Seeking Alpha Same-store sales keep accelerating, traffic was an eye-popping positive 4.5%, AUVs are still huge, and Texas Roadhouse is clearly taking share in the whole 'Battle of the Steakhouses' against Outback ( BLMN ) and LongHorn ( DRI ). The only downside to the earnings was the restaurant-level margins. I'd already warned you this was coming. Steak prices are sky-high, and cattle cycles don't turn overnight. Odds are beef costs will stay elevated for a while yet. But if steak is expensive for Texas Roadhouse, it's also expensive for its competitors. And besides Texas Roadhouse, few (I'd say one or two) steakhouses have the capacity to offer steaks at the prices they offer. And that’s really the heart of my long-term thesis here. By the time this extended cut cycle finally cools off, Texas Roadhouse will probably come out the other side with an even bigger chunk of the market and keep compounding from there. Seeking Alpha Looking at my last article in October (an earnings preview , by the way), we're at a total return of 8%, slightly above the S&P at the same stretch. But I'm aiming for ~$190 in the medium term. Almost 10% price upside post-Friday's rally, which would exceed those double digits, including dividends and share buybacks. It's a low-beta, dividend-paying stock that will reward you for waiting for that market share accumulation. But let's not jump the gun. There are a few really interesting things buried in these earnings that are worth talking through before we even get to valuation. Almost a Perfect Quarter I know I've said this many times, but Texas Roadhouse fits perfectly into the category of full-service restaurant operators with perceived value. Besides having steak at the center of everything, the...
In this article UK10Y GB20Y UK30Y Follow your favorite stocks CREATE FREE ACCOUNT British Prime Minister Keir Starmer speaks at the start of a Cabinet meeting to mark the fourth anniversary of Russia's full-scale invasion of Ukraine, at Downing Street in London, Feb. 24, 2026. Wpa Pool | Getty Images News | Getty Images Yields on U.K. government bonds surged to multi-decade highs on Tuesday mornin...
In this article UK10Y GB20Y UK30Y Follow your favorite stocks CREATE FREE ACCOUNT British Prime Minister Keir Starmer speaks at the start of a Cabinet meeting to mark the fourth anniversary of Russia's full-scale invasion of Ukraine, at Downing Street in London, Feb. 24, 2026. Wpa Pool | Getty Images News | Getty Images Yields on U.K. government bonds surged to multi-decade highs on Tuesday morning, as pressure mounted on Prime Minister Keir Starmer to resign from his post. By 8:41 a.m. in London, the yield on the benchmark 10-year gilt had jumped 10 basis points to trade at around 5.103%. Bond yields and prices move in opposite directions. Meanwhile, yields at the long end of the curve reached their highest since 1998, with the 20-year gilt yield adding 10 basis points while 30-year yields jumped 11 basis points higher. Stock Chart Icon Stock chart icon U.K. 20- and 30-year gilts Starmer's leadership is on a knife edge after more than 70 Labour lawmakers called for his resignation. The prime minister held a routine meeting with his cabinet on Tuesday morning. The calls for Starmer to resign came after the Labour Party suffered major losses in local council elections last week. Growth and living standards have stagnated in the U.K. in recent years, with the country facing a cost-of-living crisis in the wake of the Covid pandemic and the Russia-Ukraine conflict. Starmer's Labour Party has faced growing public anger at the slow pace of economic reforms, with Thursday's vote seeing huge gains for the right-wing Reform UK and the left-wing Green Party. But bond vigilantes have largely been supportive of Starmer and Reeves retaining their positions relative to potential alternatives, with U.K. bonds selling off in previous bouts of uncertainty over their political futures. Last July, yields on gilts surged after Reeves was seen crying in parliament, amid reports that her role in Starmer's cabinet was in jeopardy. It came after the government U-turned on her proposed welf...